| ACH | Acetylcholine |
| BONT | Botulinum toxin |
| BONT-A | Botulinum toxin serotype A |
| BONT-B | Botulinum toxin serotype B |
| CGRP | Calcitonin gene-related peptide |
| CM | Chronic migraine |
| CNS | Central nervous system |
| DA | Dalton |
| E2 | Estradiol |
| EM | Episodic migraine |
| FDA | Food and Drug Administration |
| FHM | Familial hemiplegic migraine |
| FSH | Follicular-stimulant hormone |
| HC | Heavy chain |
| IL | Interleukin |
| LC | Light chain |
| MA | Migraine with aura |
| MIDAS | Migraine Disability Assessment |
| MO | Migraine without aura |
| MU | Mouse Units |
| NO | Nitric Oxide |
| NOS | Nitric oxide synthase |
| NSAID | Non-steroidal anti-inflammatory drug |
| PREEMPT | Phase III Research Evaluating Migraine Prophylaxis Therapy |
| QOL | Quality of Life |
| SNAP-25 | Synaptosomal-associated protein-25 kDa |
| SNARE | Soluble NSF attachment protein receptor |
| SP | Substance P |
| TNF- A | Tumor necrosis factor alpha |
| TRP | Transient receptor potential channel |
| TRPA1 | Transient receptor potential ankyrin 1 |
| TRVP1 | Transient receptor potential cation channel subfamily V member 1 |
| VAMP | Vesicle-associated membrane protein |
| WHO | World Health Organization |